JZL195

JZL-195_Structure.svg

JZL195 is a chemical compound that acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). FAAH is responsible for the degradation of endocannabinoids, such as anandamide, which are involved in various physiological processes including pain, mood, and appetite regulation.

Chemical Properties

JZL195 is characterized by its specific inhibition of FAAH, which leads to increased levels of endocannabinoids in the body. This compound has been studied for its potential therapeutic applications in conditions such as chronic pain, anxiety, and neurodegenerative diseases.

Mechanism of Action

JZL195 inhibits FAAH by binding to the active site of the enzyme, preventing it from breaking down endocannabinoids. This results in elevated levels of anandamide and other endocannabinoids, which can then activate cannabinoid receptors (CB1 and CB2) throughout the body. Activation of these receptors has been shown to produce analgesic, anti-inflammatory, and neuroprotective effects.

Therapeutic Potential

Research on JZL195 has shown promise in several areas:

• Pain Management: By inhibiting FAAH, JZL195 increases endocannabinoid levels, which can help alleviate chronic pain.
• Anxiety Disorders: Elevated endocannabinoid levels have been associated with reduced anxiety, making JZL195 a potential treatment for anxiety disorders.
• Neuroprotection: The neuroprotective effects of endocannabinoids suggest that JZL195 could be beneficial in treating neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Side Effects and Safety

As with any pharmacological agent, the safety profile of JZL195 is an important consideration. Studies have indicated that while JZL195 is effective in increasing endocannabinoid levels, it may also produce side effects such as hypotension, bradycardia, and potential psychotropic effects due to the activation of CB1 receptors.

Research and Development

Ongoing research is focused on understanding the full therapeutic potential of JZL195, optimizing its efficacy, and minimizing any adverse effects. Clinical trials are necessary to determine its safety and effectiveness in humans.

See Also

• Endocannabinoid system
• Cannabinoid receptor
• Anandamide
• Chronic pain
• Neurodegenerative diseases

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian